Why Is LIFESTANCE HEALTH GR (LFST) Stock Up Today?

Why LFST stock is up today

LifeStance Health Group stock rose 4.12% to $13.14 on Wednesday, driven by a price target increase from Barclays and the announcement of a secondary public offering. The stock opened at $12.60 and climbed to a session high of $13.16 before settling near the high. The move follows a flurry of analyst activity and corporate actions that have drawn investor attention.

What Happened

Barclays raised its price target for LifeStance Health Group to $15 from $13, signaling improved expectations for the stock. This comes alongside the company’s announcement of a 22.25 million share secondary public offering priced at $12.35 per share. The offering includes a concurrent buyback of 2 million shares by the company. These developments, combined with a recent price target increase from Canaccord and a revised outlook from BTIG, have contributed to the stock’s upward momentum. The offering is expected to raise capital for the company while also diluting existing shareholders, as the selling stockholders, not the company, will receive the proceeds.

What The Data Shows

The stock opened at $12.60 and climbed steadily throughout the session, reaching a high of $13.16 before the close. Volume stood at 0.8 million shares, which is 0.2 times the 3-month daily average. Over the past 8 trading sessions, the stock has gained 2.8%, moving from $12.31 to $12.65. The 52-week range is $4.77 to $13.15, with the stock currently near its 52-week high. Recent insider transactions include multiple sales by executives and directors, totaling $161.6 million in the last 90 days. Meanwhile, the stock has printed nine fresh 52-week highs on September 10.

What To Watch

Investors should monitor the company’s upcoming earnings report, if scheduled, as well as continued analyst coverage. The stock remains highly volatile with a beta of 1.22 and a P/E ratio of 98.0, suggesting it is trading at a premium to earnings.